Soliton, Inc. (SOLY)
| Market Cap | 235.42M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -13.27M |
| Shares Out | 21.06M |
| EPS (ttm) | -0.74 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 26 |
| Last Price | $11.11 |
| Previous Close | $10.66 |
| Change ($) | 0.45 |
| Change (%) | 4.22% |
| Day's Open | 11.44 |
| Day's Range | 10.56 - 11.48 |
| Day's Volume | 393,133 |
| 52-Week Range | 6.02 - 14.55 |
HOUSTON, Jan. 26, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced it...
HOUSTON, Dec. 30, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced th...
Soliton, Inc. (SOLY) CEO Brad Hauser on Q3 2020 Results - Earnings Call Transcript
HOUSTON, Nov. 12, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported fin...
HOUSTON, Nov. 2, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today ann...
HOUSTON, Oct. 27, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today an...
HOUSTON, Oct. 5, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today ann...
HOUSTON, Sept. 8, 2020 /PRNewswire/ -- Soliton, Inc.
HOUSTON, Aug. 26, 2020 /PRNewswire/ -- Soliton, Inc.
HOUSTON, Aug. 20, 2020 /PRNewswire/ -- Soliton, Inc.
HOUSTON, Aug. 13, 2020 /PRNewswire/ -- Soliton, Inc.
Soliton, Inc.'s (SOLY) CEO Chris Capelli on Q2 2020 Results - Earnings Call Transcript
HOUSTON, Aug. 5, 2020 /PRNewswire/ -- Soliton, Inc.
HOUSTON, July 29, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, announced today th...
HOUSTON, July 22, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today an...
Soliton (SOLY) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Stock is down nearly 50% in the last few weeks, as a massive share offering well below where the stock was trading sparked selling.
HOUSTON, June 26, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced th...
HOUSTON, June 25, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced th...
Soliton (SOLY) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Soliton's (SOLY) CEO Chris Capelli on Q1 2020 Results - Earnings Call Transcript
HOUSTON, May 14, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported fina...
Soliton: A Solid Play On The Tattoo Removal Opportunity In 2020
These 5 stocks all have a real chance of winding up at zero — but if they can avoid that outcome, they could easily triple or more.
Soliton is developing a breakthrough technology for tattoo removal and cellulite treatment which will save time and money and have a higher degree of efficiency.
Medical device company Soliton Inc. (NASDAQ: SOLY) shares are trading higher again after the company highlighted its preclinical results for its new RAP device, which "is a potentially importa...
The company is riding high following FDA clearance for its tattoo removal medical device.
Medical device company Soliton Inc. shares are trading higher again after the company announced its decision to move forward with a pivotal trial after positive data from its proof-of-concept ...
Approval from the U.S. Food and Drug Administration (FDA) for a Soliton tattoo removal device has SOLY stock on the rise Wednesday.
Medical device company Soliton Inc. has received FDA 510(k) approval for its acoustic wave device for dermal tattoo clearing.
There is no guarantee Soliton’s RAP technology will be able to penetrate the tattoo removal market.
About SOLY
Soliton, a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers product for the removal of tattoos. It also develops product for cellulite reduction, fibrotic scar treatment, and other indications. The company was founded in 2012 and is based in Houston, Texas.
| Industry Medical Devices | IPO Date Feb 19, 2019 |
| Stock Exchange NASDAQ | Ticker Symbol SOLY |
Analyst Forecasts
According to 3 analysts, the average rating for Soliton stock is "Buy." The 12-month stock price forecast is 16.00, which is an increase of 44.01% from the latest price.